PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

Drug side effects

phenylephrine Side Effects

The reactions most often reported to the FDA for phenylephrine (also sold as Neo-Synephrine), with demographics, serious outcomes, and reporting trends.

Data updated 2026-05-15

3,669
FAERS reports

Data from the FDA Adverse Event Reporting System (FAERS), 2004 to 2025. A FAERS report records a temporal association, not proof of cause. See our methodology for how figures are compiled and de-duplicated.

The most commonly reported side effects of phenylephrine come from 3,669 reports to the FDA, broken down here by frequency, patient demographics, and serious outcomes.

This page analyzes 3,669 reports to the FDA Adverse Event Reporting System (FAERS) for phenylephrine (Neo-Synephrine): the reactions reported most often, who reported them, serious outcomes such as hospitalization, and year-over-year trends. A FAERS report does not prove the drug caused the effect, and report volume tracks how widely a drug is used, not how likely an effect is for any one person. Educational information, not medical advice.

Total Reports

3,669

Reports Mentioning Death

1,539

41.9% of reports — not proof the medicine caused the death

Hospitalizations

1,983

54.0% of reports

Top Indication

Product Used For Unknown Indication

Most Reported Adverse Reactions

PEMPHIGUS
948
JOINT SWELLING
920
PAIN
902
RHEUMATOID ARTHRITIS
872
PERICARDITIS
868
SYSTEMIC LUPUS ERYTHEMATOSUS
867
INFUSION RELATED REACTION
846
WOUND
843
GLOSSODYNIA
836
SYNOVITIS
833
ARTHROPATHY
822
CONDITION AGGRAVATED
822
MATERNAL EXPOSURE DURING PREGNANCY
806
TYPE 2 DIABETES MELLITUS
804
HEPATIC ENZYME INCREASED
791
MOBILITY DECREASED
790
RASH
786
HAND DEFORMITY
776

Who Reports Side Effects

Gender Distribution

Female 2,480 (83%)
Male 495 (17%)
Unknown 12

Age Distribution

0-17 71 (3%)
18-44 1,351 (58%)
45-64 412 (18%)
65-74 188 (8%)
75+ 290 (13%)

Reporting Trend by Year

2004 2025

Reactions in Death Reports

Top reactions reported in 1,539 reports where death was an outcome. These are voluntarily reported and do not establish causation.

Reaction Reports
FOLLICULITIS 642
HYPOAESTHESIA 641
TYPE 2 DIABETES MELLITUS 641
PEMPHIGUS 626
SYNOVITIS 625
SYSTEMIC LUPUS ERYTHEMATOSUS 622
INFUSION RELATED REACTION 609
WOUND 600
GLOSSODYNIA 598
CONDITION AGGRAVATED 596
MATERNAL EXPOSURE DURING PREGNANCY 593
PSORIATIC ARTHROPATHY 593
RHEUMATOID ARTHRITIS 592
GENERAL PHYSICAL HEALTH DETERIORATION 583
PNEUMONIA 576
WEIGHT INCREASED 572
MOBILITY DECREASED 568
PAIN 565

Reactions in Hospitalization Reports

Top reactions in 1,983 reports where hospitalization was an outcome.

Reaction Reports
CONDITION AGGRAVATED 672
PAIN 653
MOBILITY DECREASED 650
JOINT SWELLING 649
FOLLICULITIS 634
HYPOAESTHESIA 630
SYNOVITIS 619
TYPE 2 DIABETES MELLITUS 619
WOUND 617
ARTHROPATHY 608
PEMPHIGUS 608
SYSTEMIC LUPUS ERYTHEMATOSUS 602
RHEUMATOID ARTHRITIS 599
INFUSION RELATED REACTION 595
ARTHRALGIA 591
WEIGHT INCREASED 591
PNEUMONIA 589
PAIN IN EXTREMITY 585
GLOSSODYNIA 583

Compare phenylephrine vs adenosine →

What the FAERS Data Reveals About phenylephrine Side Effects

The FDA Adverse Event Reporting System (FAERS) contains 3,669 voluntary reports linked to phenylephrine and its brand equivalents (Neo-Synephrine), spanning 2004 through 2025. Of those, 1,539 (41.9%) listed death as an outcome and 1,983 (54.0%) involved hospitalization. The most common indication reported alongside adverse events was Product Used For Unknown Indication.

Demographic breakdowns help contextualize who is being exposed to the drug. Of reports with known sex, 83% were female and 17% male; age distribution skews toward 18-44, with 1,351 reports in that bracket. The single most reported reaction is pemphigus with 948 submissions, followed by joint swelling and pain.

How to read these numbers

FAERS is a signal-detection tool, not a scorecard. Reports are voluntary, and a single case may list multiple suspect drugs, so numbers above should not be read as incidence rates or per-patient risk. Widely prescribed drugs naturally accumulate more reports than niche therapies even when individual risk is low. These aggregates are useful for spotting patterns that merit further pharmacovigilance, not for choosing between medications. This page is for educational reference only and is not medical advice, speak with a licensed clinician about any side-effect concerns.

Drugs With a Similar FAERS Report Volume

Other medications with a total FDA adverse-event report count closest to phenylephrine's 3,669.